Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry

Humberto Martinez-Cordero; Virginia Abello-Polo; Claudia Casas; Maria-Helena Solano; Daniel Espinosa; Ivan Perdomo; Jheremy Reyez; Monica Osuna; Viviana Paredes; Jair Figueroa; Rigoberto Gomez; Roberto Jaramillo; Alvaro Gomez; Jose-Domingo Saavedra; Kenny Galvez; Guillermo Quintero; Lina Abenoza; Lina Gaviria; Yazmin Borjas; Henry Idrobo; William Mantilla; Claudia Sossa; Luis Salazar; Juan-Manuel Herrera; Paola Guerrero; Alvaro Guerrero; Carmen Rosales; Isabel Munevar; Carlos-Daniel Bermudez

doi:10.1016/s2152-2650(21)01612-8

Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry

Humberto Martinez-Cordero, Virginia Abello-Polo (Co-author), Claudia Casas (Co-author), Maria-Helena Solano (Co-author), Daniel Espinosa (Co-author), Ivan Perdomo (Co-author), Jheremy Reyez (Co-author), Monica Osuna (Co-author), Viviana Paredes (Co-author), Jair Figueroa (Co-author), Rigoberto Gomez (Co-author), Roberto Jaramillo (Co-author), Alvaro Gomez (Co-author), Jose-Domingo Saavedra (Co-author), Kenny Galvez (Co-author), Guillermo Quintero (Co-author), Lina Abenoza (Co-author), Lina Gaviria (Co-author), Yazmin Borjas (Co-author), Henry Idrobo (Co-author)William Mantilla (Co-author), Claudia Sossa (Co-author), Luis Salazar (Co-author), Juan-Manuel Herrera (Co-author), Paola Guerrero (Co-author), Alvaro Guerrero (Co-author), Carmen Rosales (Co-author), Isabel Munevar (Co-author), Carlos-Daniel Bermudez (Co-author)

Research output: Articles / Notes › Scientific Article

Original language	Undefined/Unknown
Journal	Clinical Lymphoma, Myeloma and Leukemia
DOIs	https://doi.org/10.1016/s2152-2650(21)01612-8
State	Published - 1 Sep 2021

Research Areas UNAB

Medicina Interna

Access to Document

10.1016/s2152-2650(21)01612-8

Cite this

Martinez-Cordero, H., Abello-Polo, V., Casas, C., Solano, M.-H., Espinosa, D., Perdomo, I., Reyez, J., Osuna, M., Paredes, V., Figueroa, J., Gomez, R., Jaramillo, R., Gomez, A., Saavedra, J.-D., Galvez, K., Quintero, G., Abenoza, L., Gaviria, L., Borjas, Y., ... Bermudez, C.-D. (2021). Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry. Clinical Lymphoma, Myeloma and Leukemia. https://doi.org/10.1016/s2152-2650(21)01612-8

Martinez-Cordero, Humberto ; Abello-Polo, Virginia ; Casas, Claudia et al. / Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry. In: Clinical Lymphoma, Myeloma and Leukemia. 2021.

@article{a523c679ed724d5da925efcc66029c0d,

title = "Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry",

author = "Humberto Martinez-Cordero and Virginia Abello-Polo and Claudia Casas and Maria-Helena Solano and Daniel Espinosa and Ivan Perdomo and Jheremy Reyez and Monica Osuna and Viviana Paredes and Jair Figueroa and Rigoberto Gomez and Roberto Jaramillo and Alvaro Gomez and Jose-Domingo Saavedra and Kenny Galvez and Guillermo Quintero and Lina Abenoza and Lina Gaviria and Yazmin Borjas and Henry Idrobo and William Mantilla and Claudia Sossa and Luis Salazar and Juan-Manuel Herrera and Paola Guerrero and Alvaro Guerrero and Carmen Rosales and Isabel Munevar and Carlos-Daniel Bermudez",

year = "2021",

month = sep,

day = "1",

doi = "10.1016/s2152-2650(21)01612-8",

language = "Indefinido/desconocido",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Elsevier Inc.",

}

Martinez-Cordero, H, Abello-Polo, V, Casas, C, Solano, M-H, Espinosa, D, Perdomo, I, Reyez, J, Osuna, M, Paredes, V, Figueroa, J, Gomez, R, Jaramillo, R, Gomez, A, Saavedra, J-D, Galvez, K, Quintero, G, Abenoza, L, Gaviria, L, Borjas, Y, Idrobo, H, Mantilla, W, Sossa, C , Salazar, L, Herrera, J-M, Guerrero, P, Guerrero, A, Rosales, C, Munevar, I & Bermudez, C-D 2021, 'Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry', Clinical Lymphoma, Myeloma and Leukemia. https://doi.org/10.1016/s2152-2650(21)01612-8

Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry. / Martinez-Cordero, Humberto; Abello-Polo, Virginia (Co-author); Casas, Claudia (Co-author) et al.
In: Clinical Lymphoma, Myeloma and Leukemia, 01.09.2021.

Research output: Articles / Notes › Scientific Article

TY - JOUR

T1 - Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry

AU - Martinez-Cordero, Humberto

A2 - Abello-Polo, Virginia

A2 - Casas, Claudia

A2 - Solano, Maria-Helena

A2 - Espinosa, Daniel

A2 - Perdomo, Ivan

A2 - Reyez, Jheremy

A2 - Osuna, Monica

A2 - Paredes, Viviana

A2 - Figueroa, Jair

A2 - Gomez, Rigoberto

A2 - Jaramillo, Roberto

A2 - Gomez, Alvaro

A2 - Saavedra, Jose-Domingo

A2 - Galvez, Kenny

A2 - Quintero, Guillermo

A2 - Abenoza, Lina

A2 - Gaviria, Lina

A2 - Borjas, Yazmin

A2 - Idrobo, Henry

A2 - Mantilla, William

A2 - Sossa, Claudia

A2 - Salazar, Luis

A2 - Herrera, Juan-Manuel

A2 - Guerrero, Paola

A2 - Guerrero, Alvaro

A2 - Rosales, Carmen

A2 - Munevar, Isabel

A2 - Bermudez, Carlos-Daniel

PY - 2021/9/1

Y1 - 2021/9/1

U2 - 10.1016/s2152-2650(21)01612-8

DO - 10.1016/s2152-2650(21)01612-8

M3 - Artículo Científico

SN - 2152-2650

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

ER -

Martinez-Cordero H, Abello-Polo V, Casas C, Solano MH, Espinosa D, Perdomo I et al. Poster: MM-435: Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide /Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1. doi: 10.1016/s2152-2650(21)01612-8